The purpose of this pilot study is to evaluate a drug called simvastatin for potential treatment of adults with recurrent acute pancreatitis or chronic pancreatitis. Participants will receive simvastatin or placebo (inactive substance); they will be asked to complete questionnaires, and blood draws. Simvastatin is approved by the U.S. Food and Drug Administration (FDA) to help lower cholesterol, but its use in this study is experimental. Researchers hope that simvastatin will have positive effects in reducing chronic pain associated with chronic pancreatitis and recurrent acute pancreatitis, in addition to improving overall quality of life and outcomes.
What is the full name of this clinical trial?
Simvastatin treatment to improve patient-reported outcomes in patients with chronic pancreatitis